Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
Standard
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. / Bartelt, Alexander; Orlando, P; Mele, C; Ligresti, A; Tödter, Klaus; Scheja, Ludger; Heeren, Jörg; Di Marzo, V.
In: DIABETOLOGIA, Vol. 54, No. 11, 11, 2011, p. 2900-2910.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance.
AU - Bartelt, Alexander
AU - Orlando, P
AU - Mele, C
AU - Ligresti, A
AU - Tödter, Klaus
AU - Scheja, Ludger
AU - Heeren, Jörg
AU - Di Marzo, V
PY - 2011
Y1 - 2011
N2 - Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB(1)) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance.
AB - Apolipoprotein E (ApoE) deficiency is associated with reduced fat accumulation in white adipose tissue (WAT) and high liver triacylglycerol content. Elevated levels of endocannabinoids and cannabinoid receptor type 1 (CB(1)) receptors in the liver and in epididymal vs subcutaneous WAT are associated with fatty liver, visceral adipose tissue, inflammatory markers and insulin resistance.
KW - Animals
KW - Male
KW - Gene Expression Regulation
KW - Cells, Cultured
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Lipid Metabolism
KW - Signal Transduction
KW - Adipose Tissue, White/immunology/metabolism
KW - Apolipoproteins E/genetics/physiology
KW - Dietary Fats/adverse effects
KW - Endocannabinoids/metabolism
KW - Fatty Liver/immunology/metabolism/pathology
KW - Hepatocytes/metabolism/pathology
KW - Inflammation Mediators/metabolism
KW - Insulin Resistance
KW - Liver/metabolism/pathology
KW - Panniculitis/immunology/metabolism
KW - RNA, Messenger/metabolism
KW - Receptor, Cannabinoid, CB1/genetics/metabolism
KW - Subcutaneous Fat/immunology/metabolism
KW - Animals
KW - Male
KW - Gene Expression Regulation
KW - Cells, Cultured
KW - Mice
KW - Mice, Inbred C57BL
KW - Mice, Knockout
KW - Lipid Metabolism
KW - Signal Transduction
KW - Adipose Tissue, White/immunology/metabolism
KW - Apolipoproteins E/genetics/physiology
KW - Dietary Fats/adverse effects
KW - Endocannabinoids/metabolism
KW - Fatty Liver/immunology/metabolism/pathology
KW - Hepatocytes/metabolism/pathology
KW - Inflammation Mediators/metabolism
KW - Insulin Resistance
KW - Liver/metabolism/pathology
KW - Panniculitis/immunology/metabolism
KW - RNA, Messenger/metabolism
KW - Receptor, Cannabinoid, CB1/genetics/metabolism
KW - Subcutaneous Fat/immunology/metabolism
M3 - SCORING: Journal article
VL - 54
SP - 2900
EP - 2910
JO - DIABETOLOGIA
JF - DIABETOLOGIA
SN - 0012-186X
IS - 11
M1 - 11
ER -